ArticleIJU case reports2026
Oncocytoma Arising From an Accessory Adrenal Gland: A Case Report.
Article in IJU case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Accessory adrenal oncocytomas are rare. Consequently, the clinical characteristics and management of this entity remain poorly defined. Case Presentation: A 65-year-old man presented with a retroperitoneal mass. Imaging revealed a 103 × 96 mm tumor adjacent to the left kidney. Hormonal evaluation indicated the tumor was nonfunctioning; however, dehydroepiandrosterone sulfate and neuron-specific enolase levels were elevated, and malignancy could not be excluded. The tumor was resected laparoscopically. Histopathological examination revealed oncocytic features, and immunohistochemistry demonstrated positivity for steroidogenic factor 1. The tumor was anatomically separate from the normal adrenal gland, supporting the diagnosis of an accessory adrenal oncocytoma. Based on the Lin-Weiss-Bisceglia criteria, the tumor was classified as borderline malignant potential. No recurrence has been observed during 2 years of follow-up. Conclusion: Accessory adrenal oncocytomas are rare entities, and their accurate diagnosis requires a comprehensive, integrated approach incorporating clinical findings, imaging studies, and detailed pathological evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.